Raymond James Financial Services Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.32M Sell
109,658
-53,627
-33% -$2.9M 0.01% 1111
2024
Q2
$7.92M Buy
163,285
+6,412
+4% +$309K 0.01% 934
2024
Q1
$7.62M Sell
156,873
-22,130
-12% -$1.08M 0.01% 931
2023
Q4
$8.9M Sell
179,003
-41,023
-19% -$2.01M 0.01% 806
2023
Q3
$11.8M Buy
220,026
+50,882
+30% +$2.71M 0.02% 643
2023
Q2
$9.12M Sell
169,144
-9,025
-5% -$486K 0.02% 743
2023
Q1
$9.7M Buy
178,169
+10,521
+6% +$512K 0.02% 709
2022
Q4
$8.12M Sell
167,648
-28,801
-15% -$1.26M 0.02% 741
2022
Q3
$7.47M Buy
196,449
+53,289
+37% +$2.37M 0.02% 743
2022
Q2
$7.16M Buy
143,160
+31,336
+28% +$1.66M 0.02% 760
2022
Q1
$5.74M Buy
111,824
+3,274
+3% +$169K 0.01% 930
2021
Q4
$5.44M Buy
108,550
+14,086
+15% +$697K 0.01% 973
2021
Q3
$4.55M Buy
94,464
+1,942
+2% +$98.7K 0.01% 1032
2021
Q2
$4.87M Sell
92,522
-2,542
-3% -$133K 0.01% 985
2021
Q1
$4.7M Buy
95,064
+7,050
+8% +$339K 0.01% 933
2020
Q4
$4.28M Buy
88,014
+909
+1% +$44.8K 0.01% 902
2020
Q3
$4.37M Buy
87,105
+913
+1% +$47K 0.01% 815
2020
Q2
$4.4M Buy
86,192
+5,256
+6% +$255K 0.01% 754
2020
Q1
$3.54M Sell
80,936
-7,796
-9% -$373K 0.02% 638
2019
Q4
$4.45M Sell
88,732
-3,681
-4% -$172K 0.01% 766
2019
Q3
$4.28M Buy
92,413
+527
+0.6% +$22.7K 0.02% 754
2019
Q2
$3.98M Sell
91,886
-11,523
-11% -$490K 0.02% 771
2019
Q1
$4.58M Buy
103,409
+6,115
+6% +$262K 0.02% 690
2018
Q4
$4.22M Sell
97,294
-3,156
-3% -$139K 0.02% 598
2018
Q3
$4.49M Sell
100,450
-1,206
-1% -$51.5K 0.02% 690
2018
Q2
$4.07M Buy
101,656
+9,674
+11% +$381K 0.02% 689
2018
Q1
$3.69M Sell
91,982
-8,878
-9% -$369K 0.02% 674
2017
Q4
$4.34M Buy
100,860
+30,280
+43% +$1.4M 0.03% 594
2017
Q3
$3.51M Sell
70,580
-1,263
-2% -$61.1K 0.02% 670
2017
Q2
$3.44M Buy
71,843
+9,513
+15% +$455K 0.02% 656
2017
Q1
$2.82M Buy
62,330
+3,183
+5% +$135K 0.02% 679
2016
Q4
$2.39M Sell
59,147
-328
-0.6% -$12.9K 0.02% 698
2016
Q3
$2.27M Sell
59,475
-34,141
-36% -$1.37M 0.02% 711
2016
Q2
$3.92M Sell
93,616
-4,790
-5% -$196K 0.04% 482
2016
Q1
$3.95M Sell
98,406
-4,533
-4% -$182K 0.05% 400
2015
Q4
$4.39M Buy
102,939
+17,135
+20% +$788K 0.05% 396
2015
Q3
$4.07M Buy
85,804
+64,551
+304% +$3.29M 0.07% 332
2015
Q2
$1.05M Sell
21,253
-1,797
-8% -$91.1K 0.08% 327
2015
Q1
$1.14M Sell
23,050
-407
-2% -$19.5K 0.06% 327
2014
Q4
$1.07M Sell
23,457
-2,043
-8% -$99.1K 0.06% 332
2014
Q3
$1.44M Sell
25,500
-2,071
-8% -$111K 0.08% 278
2014
Q2
$1.47M Sell
27,571
-5,390
-16% -$286K 0.09% 257
2014
Q1
$1.72M Sell
32,961
-1,057
-3% -$53.5K 0.1% 238
2013
Q4
$1.82M Sell
34,018
-124
-0.4% -$6.4K 0.11% 218
2013
Q3
$1.73M Sell
34,142
-4,801
-12% -$244K 0.11% 214
2013
Q2
$2.01M Buy
+38,943
New +$2.08M 0.06% 377

Other funds holding SNY

Raymond James Financial Services Advisors's SNY Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Sanofi (SNY) stake by 33% in Q3 2024, selling an estimated $2.9M and leaving 109,658 shares worth $6.32M. The position accounts for 0.01% of the portfolio, ranked #1111.

Raymond James Financial Services Advisors first reported a position in SNY in Q2 2013 and has held it in 46 quarters since. The position peaked at $11.8M in Q3 2023. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Raymond James Financial Services Advisors held 109,658 shares of Sanofi worth $6.32M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 53,627 Sanofi shares in Q3 2024, an estimated $2.9M.
  • Sanofi made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1111 holding.
  • Raymond James Financial Services Advisors first reported a position in Sanofi in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Financial Services Advisors's Sanofi position peaked at $11.8M in Q3 2023.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.